Target intelligence / Profile preview

B-cell lymphoma protein 2 family proteins (BCL-2 family)

Target
BCL-2 family
Molecular classification
Apoptosis regulator, Anti-apoptotic protein, Pro-apoptotic protein, BH3-only protein
01

Overview

The BCL-2 family is a group of evolutionarily conserved proteins that are central regulators of apoptosis, particularly the intrinsic (mitochondrial) pathway. This family includes both anti-apoptotic members such as BCL-2, BCL-xL, and Mcl-1, as well as pro-apoptotic members like Bax and Bak. The balance between these opposing factions determines cell fate in response to stress or developmental cues. Dysregulation—especially overexpression—of anti-apoptotic members like BCL‑2 is implicated in various cancers including follicular lymphoma due to chromosomal translocations such as t(14;18). Overexpression leads to resistance against programmed cell death—a hallmark of cancer progression. Therapeutic targeting with small-molecule inhibitors ("BH3 mimetics") has shown promise in hematological malignancies by restoring apoptotic sensitivity. Mcl‑1 is essential for survival across multiple immune cell types including T lymphocytes at various developmental stages.

Other names
BCL2 familyBcl-2/Bcl-xL/Mcl-1BCL-2 proteinsApoptosis regulators
02

Mechanism of action

Inhibition of anti-apoptotic proteins, activation of pro-apoptotic proteins, promotion of cytochrome c release from mitochondria

03

Biological functions

ApoptosisRegulation of mitochondrial outer membrane permeabilityControl of cytochrome c releaseAutophagyCalcium signalingRegulation of mitochondrial dynamicsRegulation of mitochondrial energetics
04

Disease associations

CancerAutoimmune disease
05

Safety considerations

Resistance to apoptosisPotential for off-target effects with inhibitors
06

Interacting drugs

BH3 mimetics

1 more in the full profile.

Beyond the preview

Go deeper on B-cell lymphoma protein 2 family proteins (BCL-2 family).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on B-cell lymphoma protein 2 family proteins (BCL-2 family).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call